{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:56:50Z","timestamp":1790621810331,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011960","name":"Debra International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011960","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.omtn.2019.09.011","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T18:43:20Z","timestamp":1569005000000},"page":"496-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Improved Double-Nicking Strategies for COL7A1-Editing by Homologous Recombination"],"prefix":"10.1016","volume":"18","author":[{"given":"Thomas","family":"Kocher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland N.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Klausegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Guttmann-Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hainzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Reichelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2019.09.011_bib1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.omtn.2019.09.011_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-016-0489-9","article-title":"Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases","volume":"11","author":"Montaudi\u00e9","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtn.2019.09.011_bib3","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/bjd.12599","article-title":"Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial","volume":"169","author":"Petrof","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.omtn.2019.09.011_bib4","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.2016.15588","article-title":"Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa","volume":"316","author":"Siprashvili","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.omtn.2019.09.011_bib5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jaad.2013.08.014","article-title":"A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa","volume":"69","author":"Venugopal","year":"2013","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.omtn.2019.09.011_bib6","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1172\/JCI92707","article-title":"Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients","volume":"127","author":"Woodley","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2019.09.011_bib7","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/mt.2010.91","article-title":"SIN retroviral vectors expressing COL7A1 under human promoters for ex\u00a0vivo gene therapy of recessive dystrophic epidermolysis bullosa","volume":"18","author":"Titeux","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.09.011_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2019.09.011_bib9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2019.09.011_bib10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2019.09.011_bib11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2019.09.011_bib12","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2019.09.011_bib13","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2019.09.011_bib14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41586-018-0500-9","article-title":"In\u00a0vivo CRISPR editing with no detectable genome-wide off-target mutations","volume":"561","author":"Akcakaya","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2019.09.011_bib15","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/npjregenmed.2016.14","article-title":"CRISPR\/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa","volume":"1","author":"Webber","year":"2016","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.omtn.2019.09.011_bib16","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.ymthe.2017.07.005","article-title":"COL7A1 Editing via CRISPR\/Cas9 in Recessive Dystrophic Epidermolysis Bullosa","volume":"25","author":"Hainzl","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.09.011_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.omtn.2018.06.008","article-title":"Ex\u00a0Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR\/Cas9 and Homology-Directed Repair","volume":"12","author":"Izmiryan","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2019.09.011_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.omtn.2018.01.009","article-title":"Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells","volume":"11","author":"Menc\u00eda","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2019.09.011_bib19","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ymthe.2019.03.007","article-title":"Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR\/Cas9-Mediated Gene Editing","volume":"27","author":"Bonafont","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.09.011_bib20","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jid.2019.02.015","article-title":"Efficient gene reframing therapy for recessive dystrophic epidermolysis bullosa using CRISPR\/Cas9","volume":"139","author":"Takashima","year":"2019","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.omtn.2019.09.011_bib21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nbt.2675","article-title":"CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering","volume":"31","author":"Mali","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2019.09.011_bib22","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2019.09.011_bib23","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.ymthe.2017.08.015","article-title":"Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR\/Cas9 Nickases","volume":"25","author":"Kocher","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.09.011_bib24","first-page":"292","article-title":"Identification of two splicing mutations in the collagen type VII gene (COL7A1) of a patient affected by the localisata variant of recessive dystrophic epidermolysis bullosa","volume":"59","author":"Gardella","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2019.09.011_bib25","doi-asserted-by":"crossref","first-page":"W401","DOI":"10.1093\/nar\/gku410","article-title":"CHOPCHOP: a CRISPR\/Cas9 and TALEN web tool for genome editing","volume":"42","author":"Montague","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.omtn.2019.09.011_bib26","doi-asserted-by":"crossref","first-page":"W272","DOI":"10.1093\/nar\/gkw398","article-title":"CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering","volume":"44","author":"Labun","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.09.011_bib27","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1093\/nar\/gku402","article-title":"CRISPR\/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences","volume":"42","author":"Lin","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.09.011_bib28","first-page":"169","article-title":"Heteroduplex formation in polymerase chain reaction","volume":"47","author":"Anglani","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2019.09.011_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41467-017-00687-1","article-title":"In trans paired nicking triggers seamless genome editing without double-stranded DNA cutting","volume":"8","author":"Chen","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2019.09.011_bib30","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","article-title":"Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases","volume":"30","author":"Bae","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2019.09.011_bib31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.addr.2017.12.003","article-title":"Functional therapies for cutaneous wound repair in epidermolysis bullosa","volume":"129","author":"Peking","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2019.09.011_bib32","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","article-title":"Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells","volume":"12","author":"Mavilio","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2019.09.011_bib33","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jid.2016.10.038","article-title":"Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells","volume":"137","author":"Bauer","year":"2017","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.omtn.2019.09.011_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature24487","article-title":"Regeneration of the entire human epidermis using transgenic stem cells","volume":"551","author":"Hirsch","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2019.09.011_bib35","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1038\/mtna.2016.19","article-title":"Gene Editing for the Efficient Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes","volume":"5","author":"Chamorro","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2019.09.011_bib36","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1073\/pnas.1512028113","article-title":"Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa","volume":"113","author":"Shinkuma","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.09.011_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nbt.4317","article-title":"Predicting the mutations generated by repair of Cas9-induced double-strand breaks","volume":"37","author":"Allen","year":"2018","journal-title":"Nat Biotechnol."},{"key":"10.1016\/j.omtn.2019.09.011_bib38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.molcel.2018.11.031","article-title":"Target-Specific Precision of CRISPR-Mediated Genome Editing","volume":"73","author":"Chakrabarti","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2019.09.011_bib39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41586-018-0686-x","article-title":"Predictable and precise template-free CRISPR editing of pathogenic variants","volume":"563","author":"Shen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2019.09.011_bib40","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity","volume":"17","author":"Kern","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.09.011_bib41","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/bjd.13945","article-title":"A COL7A1 variant leading to in-frame skipping of exon 15 attenuates disease severity in recessive dystrophic epidermolysis bullosa","volume":"173","author":"Schwieger-Briel","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.omtn.2019.09.011_bib42","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.1614775114","article-title":"Efficient in\u00a0vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model","volume":"114","author":"Wu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.09.011_bib43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jbiotec.2015.04.024","article-title":"Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection","volume":"208","author":"Liang","year":"2015","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.omtn.2019.09.011_bib44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jbiotec.2016.11.011","article-title":"Enhanced CRISPR\/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA","volume":"241","author":"Liang","year":"2017","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.omtn.2019.09.011_bib45","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1038\/mtna.2016.3","article-title":"A Gene Gun-mediated Nonviral RNA trans-splicing Strategy for Col7a1 Repair","volume":"5","author":"Peking","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2019.09.011_bib46","doi-asserted-by":"crossref","first-page":"10259","DOI":"10.1093\/nar\/gkx669","article-title":"An RNA-targeted therapy for dystrophic epidermolysis bullosa","volume":"45","author":"Peking","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.09.011_bib47","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/gt.2016.57","article-title":"Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations","volume":"23","author":"Tockner","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2019.09.011_bib48","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119302586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119302586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:36:00Z","timestamp":1784651760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253119302586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":48,"alternative-id":["S2162253119302586"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2019.09.011","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved Double-Nicking Strategies for COL7A1-Editing by Homologous Recombination","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2019.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}